Summary
This 8-K/A filing from Abbott Laboratories (ABT) serves as an amendment and clarification regarding the frequency of the advisory vote on executive compensation. Following the Annual Meeting of Shareholders held on April 28, 2017, and based on shareholder votes, the Board of Directors has formally determined that Abbott will hold an annual advisory vote on the compensation of its named executive officers. This decision aligns with the recommendation of the Board and the expressed sentiment of the shareholders as reflected in the voting results. The filing incorporates by reference details from a previous 8-K filed on May 3, 2017, which summarized the matters voted upon during the annual meeting.
Key Highlights
- 1Abbott Laboratories' Board of Directors has decided to hold an annual advisory vote on executive compensation.
- 2This decision was made following the Annual Meeting of Shareholders on April 28, 2017.
- 3The Board's decision was based on voting results from the annual meeting and the Board's own recommendation.
- 4The filing is an amendment to a previous 8-K filing dated May 3, 2017.
- 5The May 3, 2017 8-K, which summarized the shareholder vote, is incorporated by reference into this filing.
- 6Brian B. Yoor, Executive Vice President, Finance and Chief Financial Officer, signed the report.